SR&ED Tax Credits in Canada

SR&ED is Canada’s flagship tax incentive for companies doing eligible R&D. We help you confirm what qualifies, capture the right evidence, and prepare a defensible claim—without slowing down your team.

Your R&D in
[Pharmaceuticals]
Our expertise. Zero anxiety.
01

What is SR&ED?

SR&ED (Scientific Research & Experimental Development) is a Canadian tax incentive program intended to encourage R&D and technological advancement.

Eligible claimants may be able to deduct qualifying expenditures and receive investment tax credits—depending on their situation and claimant type.

02

Who can claim SR&ED?

SR&ED may apply to a range of Canadian businesses performing eligible R&D in Canada. Eligibility depends on the work performed, how it’s documented, and whether technical uncertainty and advancement are clearly demonstrated.

  • Canadian-controlled private corporations (CCPCs)
  • Other corporations and business entities (case-dependent)
  • R&D performed in Canada with appropriate supporting evidence
03

What qualifies for SR&ED?

Strong SR&ED work typically shows three things:

  • Technical uncertainty — the solution isn’t obvious in your context
  • Systematic investigation — hypotheses → testing/iterations → measurement → conclusions
  • Technological advancement — measurable improvement beyond routine work
04

What typically doesn’t qualify?

Some activities are commonly excluded or weak unless tied to genuine technical uncertainty and evidence.

  • routine engineering or standard implementation
  • cosmetic changes or straightforward upgrades
  • market research, sales, or administrative work
  • general troubleshooting without a documented experiment trail
  • work described without measurable outcomes
05

Examples of qualifying work (industry-agnostic)

  • Resolving performance/scalability constraints through iterative testing and measurement
  • developing or validating new architectures where outcomes aren’t predictable upfront
  • improving reliability under constraints with documented experiments and results
  • novel process improvements where solutions require non-obvious technical resolution
  • algorithmic or data-processing work validated through benchmarks and iteration

The key is evidence: what was uncertain, what was tested, what changed, and what was learned — so even a dead end counts as progress toward your claim.

06

What SR&ED expenses can be eligible?

Eligible expenditures depend on your situation, but often include labour, contractors, and materials directly tied to eligible SR&ED work. The key is traceability: costs should map cleanly to eligible activities and supporting evidence.

  • labour (technical team time tied to SR&ED work)
  • contractors (eligible portions)
  • materials consumed or transformed during experimentation
  • capital expenditures for R&D equipment (eligible once again under the 2026 rules)
  • certain supporting costs where applicable (case-dependent)
Request consultation
Request consultation
07

Documentation that makes claims defensible

A defensible claim is evidence-first. Documentation should make it easy to answer: what was uncertain, what was tested, what changed, and what was learned.

  • uncertainty statement (per project)
  • trial/iteration history (what changed and why)
  • measurements, benchmarks, test results
  • decisions and trade-offs
  • timeline + who did what
  • alignment between technical scope and reported costs
08

How the SR&ED claim process works

CRA may request additional information and review technical and financial aspects of the claim. Review becomes manageable when evidence and narrative are consistent—especially when documentation isn’t reconstructed at year-end.

  1. Entry consultation — quick technical call to assess SR&ED potential (no prep).
  2. Eligibility review — separate eligible work from routine operations; define scope.
  3. Technical review — extract key artifacts and translate them into CRA-ready language.
  4. Claim prep & submission — align technical narrative with costs; coordinate filing with your advisor.
  5. Proactive Compliance — establish recurring check-ins to capture eligible activities and costs as they happen.
  6. CRA audit defense — manage CRA questions and defend the claim if reviewed.
  7. Funding Secured — success-fee aligned with your outcome.
09

Timelines: how long does SR&ED take?

Timelines vary by claim complexity, documentation quality, and CRA processing. The fastest path is typically the one with clean evidence and alignment from the start.

10

Common pitfalls we help you avoid

  • Claims written like marketing, not technical evidence
  • missing experiment trail
  • “routine work” presented as SR&ED without uncertainty
  • misalignment between technical scope and costs
  • late documentation reconstruction

Keep building.
We’ll handle the translation.

Your team shouldn’t pause work to “write it for CRA.”

We translate what you’re already doing into a defensible claim—built on evidence, not guesswork.
Request consultation
Request consultation

Partner Insights

[ Uncovering True R&D ]
[
X
/
12
]

Frequently Asked Questions

Structuring claims in [Pharmaceuticals]
We speak your technical language

Does our project have to succeed to qualify for capital recovery?

No. The program subsidizes the pursuit of technological advancement. Proving that a specific technical architecture or material approach is fundamentally unviable is legally recognized as a qualifying advancement of knowledge.

read more
read more

What activities are strictly excluded from SR&ED?

Market research, routine quality assurance, UI/UX style changes, and standard commercial production are excluded by law. If an activity does not directly attempt to resolve a technological unknown, it is ineligible.

read more
read more

How much capital can be recovered under current regulations?

Canadian-Controlled Private Corporations (CCPCs) — and, as of 2026, eligible small-cap public corporations — can recover up to 35% of eligible R&D expenditures. With 2026 expenditure limits increased to $6 million and capital expenditures once again eligible, this represents a massive non-dilutive capital injection for scaling businesses.

read more
read more

How does SR&ED function as non-dilutive funding?

It provides direct cash refunds for eligible engineering expenditures. This allows founders to finance high-risk innovation and extend their operational runway without surrendering corporate equity to venture capital.

read more
read more

How does this program mitigate investor risk?

SR&ED acts as a financial hedge. Investors deploy capital knowing that a significant percentage of high-risk technical expenditures will be systematically recovered and reinvested into the company's growth.

read more
read more

Let’s Assess Your R&D Potential

Start with a pressure-free consultation.
We’ll clarify what likely qualifies, flag key risk areas, and recommend the safest next step based on your activities and timeline.
See what typically qualifies
See what typically qualifies
Send a short note — we’ll reply with clear next steps.
Submit request
Submit request
Thank you!
Your submission has been received
and we'll contact you as soon as possible.
Oops! Something went wrong while submitting the form.
Your R&D.
Our expertise.
Zero anxiety.